U.S. Residents Only, 18 Years and Older.
HOME
|
CONTACT US
|
INDEX
BMS.com-US
Study Connect Home
About Clinical Studies
What is a clinical study?
Who can participate?
Are there any risks to participants?
What investigational drug names are used in clinical study listings
Understanding clinical study phases
What is Informed Consent?
How are participants protected?
Clinical Study Insights
Pediatric Clinical Studies
Why are pediatric clinical studies important?
Video Gallery: What people are saying
Informed consent in pediatric studies
Caregivers
Some considerations for caregivers of study participants
Informed consent for caregivers
Caregiver resources
Clinical Study FAQs
Study ID (Protocol Number)
AI443-006
STUDY LOCATIONS*
Pra International
Lenexa, KS 66219
Terminated
*Not all study site locations may be listed - please check back soon for updated
information. For more information regarding other participating countries, please
visit
clinicaltrials.gov
.
STUDY NAME
Study to
Assess
the Effect of BMS-791325 on the
Pharmacokinetics
of Midazolam in Healthy
Subjects
STUDY OVERVIEW
The purpose of this study is to
assess
the effect of BMS-791325 on the
pharmacokinetics
of the
CYP3A4
Probe Midazolam.
The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit
ClinicalTrials.gov
for complete information about this and other clinical studies.